TVTX — Travere Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Travere Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	399	362	553	450	567
Net Total Accounts Receivable
Net Total Receivables	18	33.1	16.2	16.6	21.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	429	410	583	486	617
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.89	35.1	34.3	30	25.5
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	605	607	777	673	789
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	95.4	92.7	124	142	178
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	384	396	475	630	588
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	221	211	302	42.9	201
Total Liabilities & Shareholders' Equity	605	607	777	673	789
Total Common Shares Outstanding